[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"delirium-in-the-intensive-care-unit\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:delirium-in-the-intensive-care-unit":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,49,79,105,129,156,179,199,227],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100641417","virtual-reality-to-reduce-anxiety-agitation-and-delirium-in-critically-ill-patients-100641417",false,"NCT07649876","Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients","Inclusion Criteria:\n\n1. Aged ≥ 18 years old admitted to the Surgical Intensive Care Unit (SICU) at Penn State Health Milton S. Hershey Medical Center.\n2. No significant uncorrectable visual or auditory impairments\n3. Estimated ICU length of stay \\> 48h\n4. At the time of each VR session, able to keep eyes open for at least 30 seconds, follow simple commands and able to indicate discomfort or request to stop.\n5. English speaking\n\nExclusion Criteria:\n\n1. Significant hemodynamic instability\n2. Known psychotic disorders associated with delusions (e.g. schizophrenia)\n3. Severe dementia (e.g. inability to communicate or follow simple commands)\n4. History of disequilibrium syndrome or vertigo\n5. Acute hyperactive delirium, requiring physical restraints",true,"ALL",{"count":18,"type":19},30,"ESTIMATED","INTERVENTIONAL",[22],"NA","This is a pilot feasibility study examining the use of immersive virtual reality (VR) in adult intensive care unit (ICU) patients. The study evaluates whether brief, non-interactive VR sessions delivered using a commercially available standalone head-mounted display with calming, nature-based content can be delivered safely and effectively within routine SICU workflow. Exploratory objectives assess whether VR sessions are associated with changes in anxiety, agitation, delirium, pain, and sedative medication requirements. This research is not intended to evaluate the safety or effectiveness of the headset and\u002For the specific VR software used for the research",[25,26,27,28],"Delirium in the Intensive Care Unit","Sleep Quality in Adult ICU Patients","Agitation Associated With Critical Illness","Anxiety Acute",[30,31,32,33,34,35],"Virtual reality","Intensive care unit","Pain","Agitation","Anxiety","Sleep Quality","RECRUITING","2026-06-17",{"date":39,"type":40},"2026-06-22","ACTUAL",{"date":42,"type":40},"2026-06-02",{"date":44,"type":19},"2026-09",{"name":46,"class":47},"Milton S. Hershey Medical Center","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":54,"acronym":4,"eligibilityCriteria":55,"healthyVolunteers":15,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":57,"targetDuration":4,"studyType":20,"phases":59,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":48},"100643704","precision-icu-care-evaluating-an-ai-driven-nursing-decision-support-system-for-delirium-prevention-100643704","NCT07631494","Precision ICU Care: Evaluating an AI-Driven Nursing Decision Support System for Delirium Prevention","Efficacy of an Intelligent Computational Nursing Decision Support System in Precision Critical Care for Delirium Prevention: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged 18 years\n* High risk of developing delirium are defined as PRE-DELIRIC (PREdiction of DELIRium in ICu patients) with a score of ≥40%\n* Sedation assessment form (Richmond Agitation-Sedation). Scale, RASS) is assessed as between +1 and -1\n* Patient is clearly aware and able to communicate with Chinese and Taiwanese customers.\n\nExclusion Criteria:\n\n* Those who have developed delirium before joining the study (assessed by the Intensive Care Delirium Screening Checklist (ICDSC) \\>4 points)\n* Expected to stay in the ICU for less than 24 hours\n* APACHE II score \\> 25 (meaning \\> 50% mortality)\n* Delirium cannot be evaluated, such as those with severe acute brain injury, audio-visual impairment, speech problems, psychotic disorders, aphasia, or in the entire ICU During this period, patient remained comatose.","18 Years",{"count":58,"type":19},188,[22],"Delirium affects up to 83% of mechanically ventilated patients in the Intensive Care Unit (ICU), often leading to longer hospital stays and long-term memory or cognitive problems. While standard care protocols (such as the ABCDEF bundle) exist, they are often difficult to implement fully due to their complexity and the heavy workload on nursing staff.\n\nTo address these challenges, this study introduces a 'Precision Nursing' approach by integrating Artificial Intelligence (AI) and Virtual Reality (VR). We will implement an AI-driven system to assist nurses in making personalized care decisions more efficiently. Additionally, interactive VR technology will be used to stimulate patients' cognitive function and encourage early mobility. Our goal is to reduce the clinical burden on healthcare providers while significantly improving recovery outcomes for ICU patients.",[25,35],[63,64,65,66,67,68],"Artificial Intelligence","delirium","intensive care unit","Virtual Reality","sleep","machine learning","NOT_YET_RECRUITING","2026-06-01",{"date":72,"type":40},"2026-06-08",{"date":74,"type":19},"2026-06",{"date":76,"type":19},"2028-06",{"name":78,"class":47},"Taipei Medical University",{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":84,"acronym":85,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":56,"enrollmentInfo":87,"targetDuration":4,"studyType":20,"phases":89,"briefSummary":90,"conditions":91,"keywords":92,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":48},"100636158","therapeutic-cuddling-in-critically-ill-children-100636158","NCT07562048","Therapeutic Cuddling in Critically Ill Children","Therapeutic Cuddling in Critically Ill Kids (THE ChICKS) Pilot Feasibility Randomized Controlled Trial","THE ChICKS","Inclusion Criteria:\n\n\\- expected duration of admission of \\> 48 hours.\n\nExclusion Criteria:\n\n* Previously enrolled",{"count":88,"type":19},112,[22],"2.1 CONTEXT Pain and agitation are common comorbidities of pediatric critical illness due to both underlying disease processes and ICU related therapies. These are associated with both short and long term negative sequelae including increased mortality, length of stay, rates of ICU delirium, worse sleep, increased anxiety, depression, and chronic pain. The current standard of care to manage PICU associated pain and agitation is the use of analgosedation (e.g. opioids and benzodiazepines) these too are associated with increased time on the ventilator, length of stay, ICU delirium, and long term mental health and negative neuro-cognitive outcomes. Despite recommendations for increased use of non-pharmacologic therapies in the prevention and management of PICU associated pain, agitation, delirium, and analgosedation exposure, there are currently know therapies with clear evidence of efficacy.\n\nTherapeutic cuddling (e.g. kangaroo care, clothed cuddling, comfort holding, etc.) has been shown to decrease pain and anxiety in critically ill neonates, and healthy children and adults. Positive affective touch and hugging has known physiologic benefits and has been associated with decreased pain, improved immunity, and decreased mortality. Despite the potential for this intervention to aid in the prevention and management of PICU associated pain, agitation, delirium and analgosedation exposure, little data exists on efficacy of therapeutic cuddling in critically ill children.\n\n2.2 OBJECTIVES 2.2.1 Primary Determine the feasibility of screening, consent, randomization, and retention of participants in a pragmatic RCT of therapeutic cuddling versus standard of care in the Alberta Children's Hospital Pediatric Intensive Care Unit.\n\n2.2.2 Secondary\n\n1. Determine treatment fidelity of participants randomized to the intervention arm.\n2. Determine the prevalence of the therapeutic cuddling intervention in those randomized to the standard of care arm.\n3. Determine the feasibility of measurement of key outcomes and co-variates (i.e., pain, agitation, sedation, delirium, analgosedation exposure, parental presence).\n4. Describe the experience of patients, caregivers, and healthcare professionals in delivering\u002Freceiving the therapeutic cuddling intervention.\n\n2.3 STUDY DESIGN Pilot feasibility randomized controlled trial of a structured co-designed therapeutic cuddling intervention as compared to the standard of care in a single tertiary care PICU.\n\n2.4 DURATION 6 months to 1 year 2.5 LOCATION, DEPARTMENTS, AND FACILITY WHERE RESEARCH WILL BE UNDERTAKEN The pediatric intensive care unit at the Alberta Children's Hospital 2.6 SAMPLE SIZE A total sample size of 112 participants (56 per arm)",[32,25],[93,94,32,95,33],"Therapeutic cuddling","PICU","Delirium","2026-04-27",{"date":98,"type":40},"2026-05-01",{"date":100,"type":40},"2025-12-08",{"date":102,"type":19},"2026-12",{"name":104,"class":47},"University of Calgary",{"id":106,"slug":107,"hasResults":11,"nctId":108,"briefTitle":109,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":16,"minAge":111,"maxAge":4,"enrollmentInfo":112,"targetDuration":4,"studyType":20,"phases":114,"briefSummary":116,"conditions":117,"keywords":4,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":125,"leadSponsor":127,"locationsCount":48},"100635115","phase-3-phenobarbital-for-agitated-delirium-100635115","NCT07548489","Phenobarbital for Agitated Delirium","Inclusion Criteria:\n\n* Adult Patients identified by providers to have agitated or hyperactive delirium\n\nExclusion Criteria:\n\n* Pregnancy\n* Incarceration\n* Severe liver disease\n* Allergy or prior adverse reaction to phenobarbital or antipsychotic drugs (depending on the month of therapy initiation)","21 Years",{"count":113,"type":19},150,[115],"PHASE3","The goal of this clinical trial is to test whether the medication phenobarbital is as effective for treating agitated delirium among adult patients admitted to the intensive care unit. Agitated delirium is a condition involving confusion and impulsiveness which is dangerous to both patients and healthcare providers.\n\nThe main questions this trial aims to answer include:\n\n* Can phenobarbital decrease the amount of time patients with agitated delirium spend in the intensive care unit and the hospital?\n* Does phenobarbital decrease the amount of additional calming medications patients with agitated delirium need?\n\nResearchers in this study will compare phenobarbital to other medications commonly used to treat agitated delirium.\n\nParticipants will be monitored closely to make sure they remain safe and to measure how well their agitation and confusion are managed while they are in the ICU.",[118,119,25,120],"Agitated Delirium","Delirium Confusional State","Hyperactive Delirium","2026-04-17",{"date":123,"type":40},"2026-04-23",{"date":74,"type":19},{"date":126,"type":19},"2027-07",{"name":128,"class":47},"Duke University",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":135,"eligibilityCriteria":136,"healthyVolunteers":11,"sex":16,"minAge":137,"maxAge":56,"enrollmentInfo":138,"targetDuration":4,"studyType":20,"phases":140,"briefSummary":141,"conditions":142,"keywords":143,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":147,"startDateStruct":149,"completionDateStruct":151,"leadSponsor":153,"locationsCount":155},"100634692","phase-3-impact-on-delirium-of-the-use-of-dexmedetomidine-as-first-line-sedation-in-pediatric-intensive-care-100634692","NCT07542990","Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care","Impact on Delirium of the Use of DEXmedetomidine as First-line Sedation in PEDIAtric Intensive Care: the PEDIADEX Randomized Controlled Trial","PEDIADEX","Inclusion Criteria:\n\n* Children between 1month to 17 years and 6 months\n* Sedation and analgesia for mechanical ventilation for more than 12 hours\n* Participants covered by or entitled to French social security\n* Informed consent, dated and signed, from the participant's legal representative(s). (The emergency inclusion procedure will be used if the legal representative(s) cannot be contacted. When the legal representative(s) and the patient are available and\u002For able to consent, informed consent from the participant's legal representative(s)\n* Ability for participant to comply with the requirements of the study\n* Receiving sedation by benzodiazepines for less than 6 hours at the time of inclusion\n\nExclusion Criteria:\n\n* Patients under guardianship, curatorship or legal protection\n* Pregnant or breastfeeding woman (positive pregnancy test for women of childbearing age)\n* High-grade heart conduction disorder (Second or third-degree atrioventricular block)\n* Status epilepticus\n* Intracranial hypertension\n* Sedation for more than 6 hours by benzodiazepines at the time of inclusion\n* Need for paralytic medication (neuromuscular blocker) at admission to PICU\n* Following cardiac surgery\n* Palliative care on admission\n* Significant bradycardia\n* Severe hepatic dysfunction (CHILD score C or worse) due to the hepatic metabolism of dexmedetomidine\n* Patient already enrolled in the study previously\n* Expected duration of invasive mechanical ventilation inferior to 12 hours\n* Hospitalized in a pediatric intensive care unit without computerized prescription software","1 Month",{"count":139,"type":19},266,[115],"The goal of this clinical trial is to learn if dexmedetomidine can reduce delirium in critically ill children, needing mechanical ventilation for more than 12 hours. The main question it aims to answer is :\n\n• Does dexmedetomidine reduce the proportion of children presenting at least one episode of delirium during their intensive care unit (ICU) stay ? Researchers will compare dexmetomidine to midazolam, to see if the use of dexmedetomidine reduces the prevalence of delirium.\n\nParticipants will be sedated with midazolam or dexmedetomidine, according to randomization arm, and the rest of sedation is determined by the study protocol.",[25],[64,144,145,146,65],"pediatric","dexmedetomidine","midazolam",{"date":148,"type":40},"2026-04-21",{"date":150,"type":19},"2026-04-15",{"date":152,"type":19},"2029-08-15",{"name":154,"class":47},"University Hospital, Tours",7,{"id":157,"slug":158,"hasResults":11,"nctId":159,"briefTitle":160,"officialTitle":160,"acronym":4,"eligibilityCriteria":161,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":162,"targetDuration":4,"studyType":164,"phases":4,"briefSummary":165,"conditions":166,"keywords":167,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":171,"lastUpdatePostDateStruct":172,"startDateStruct":173,"completionDateStruct":174,"leadSponsor":176,"locationsCount":48},"100630251","eeg-abnormalities-in-adult-icu-patients-with-high-risk-of-delirium-100630251","NCT07485244","EEG Abnormalities in Adult ICU Patients With High Risk of Delirium","Inclusion Criteria:\n\n* Adult patient ≥18 years old\n* Requiring admission to a medical, surgical and\u002For cardiovascular ICU for an expected duration ≥ 24 hours\n* Receiving treatment for shock (e.g., with vasopressors, intra-aortic balloon pump, or Extracorporeal Membrane Oxygenation therapy) and\u002For respiratory failure \\[e.g., on mechanical ventilation or non-invasive positive pressure ventilation (NIPPV)\\].\n\nExclusion Criteria:\n\n* Any structural abnormality or head condition, including the presence of a device, that would prevent the use of the Ceribell EEG system for the entire anticipated EEG monitoring period. Examples include: Craniectomy with a missing bone flap in a region where Ceribell EEG electrodes would be placed.\n* Anticipated use of continuous EEG for a purpose other than delirium detection during the entire expected monitoring period.\n* Patients who have been on mechanical ventilation for \\>72 hours within the current hospitalization or who are on long-term ventilator support prior to the injury that resulted in the current hospitalization.\n* Expected death within 12 hours of enrollment or lack of commitment to treatment by family or the medical team (e.g., likely to withdraw life support measures within 12 hours of enrollment).\n* Acute or chronic neurologic deficit precluding CAM-ICU assessments\n* Inability to understand English\n* Bilateral Deafness\n* Blindness that will preclude delirium evaluation\n* Current enrollment in a study that does not allow co-enrollment\n* Inability to obtain informed consent\n* Attending physician refusal\n* Patient and\u002For surrogate refusal\n* Patient unable to consent and no surrogate available\n* Prisoners",{"count":163,"type":19},100,"OBSERVATIONAL","The purpose of this study is to assess the prevalence of EEG abnormalities on Ceribell POC EEG in adult medical, surgical, and cardiovascular ICU patients with high risk of delirium",[25],[168,169,170,95],"Ceribell","Electroencephalogram (EEG)","Delirium monitoring","2026-04-16",{"date":148,"type":40},{"date":171,"type":40},{"date":175,"type":19},"2027-09-30",{"name":177,"class":178},"Ceribell Inc.","INDUSTRY",{"id":180,"slug":181,"hasResults":11,"nctId":182,"briefTitle":183,"officialTitle":183,"acronym":184,"eligibilityCriteria":185,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":186,"targetDuration":4,"studyType":20,"phases":187,"briefSummary":188,"conditions":189,"keywords":190,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":192,"lastUpdatePostDateStruct":193,"startDateStruct":195,"completionDateStruct":197,"leadSponsor":198,"locationsCount":48},"100627498","ceribell-delirium-monitor-outcomes-pilot-study-100627498","NCT07449416","Ceribell Delirium Monitor Outcomes Pilot Study","DOM","Inclusion Criteria:\n\n* Age is 18 years or older\n* Admitted to the ICU for an expected duration ≥ 24 hours from enrollment\n* Have at least one of the following conditions:\n\nAcute Sepsis or Septic Shock Admitted to the ICU following elective cardiothoracic surgery Acute respiratory failure requiring non-invasive ventilation or high-flow nasal cannula (HFNC) oxygenation Shock requiring vasopressor therapy Mechanically ventilated - Current RASS ≥ -3 and not expected to require deep sedation (RASS \\\u003C -3) during the ICU stay\n\nExclusion Criteria:\n\n\\- Any structural abnormality or head condition, including the presence of a device, that would prevent the use of the Ceribell EEG system for the entire anticipated EEG monitoring period. Examples include: Craniectomy with a missing bone flap in a region where Ceribell EEG electrodes would be placed.\n\nAnticipated use of continuous EEG for a purpose other than delirium detection during the entire expected monitoring period.\n\n* Baseline neurological dysfunction (Glasgow Coma Scale \\\u003C 10) and pre-existing brain injuries such as stroke with known deficits, severe TBI\n* History of moderate-severe dementia (IQCODE ≥ 3.5)\n* APACHE II score \\> 30, or SOFA \\> 9 at enrollment",{"count":163,"type":19},[22],"This pilot study is designed as a pre- and post-delirium monitor cohort study, with a prospective intervention cohort and a retrospective control cohort.",[25],[95,191,168,169],"Delirium Monitoring","2026-02-27",{"date":194,"type":40},"2026-03-04",{"date":196,"type":19},"2026-03-15",{"date":102,"type":19},{"name":177,"class":178},{"id":200,"slug":201,"hasResults":11,"nctId":202,"briefTitle":203,"officialTitle":204,"acronym":4,"eligibilityCriteria":205,"healthyVolunteers":11,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":206,"targetDuration":4,"studyType":164,"phases":4,"briefSummary":208,"conditions":209,"keywords":214,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":218,"lastUpdatePostDateStruct":219,"startDateStruct":221,"completionDateStruct":223,"leadSponsor":225,"locationsCount":48},"100575320","family-involvement-in-icu-100575320","NCT06770751","Family Involvement in ICU","Family Involvement in the Intensive Care Unit: a Prospective Cohort Study Exploring Its Effects on Sedation Dosages, Delirium, Ventilator-Free Days, and Length of Stay.","Inclusion Criteria:\n\n* Patients aged 18 and over.\n* Patients with at least one family member actively involved in the care process in the ICU.\n\nExclusion Criteria:\n\n* Patients with pre-existing cognitive impairment or dementia.\n* Patients with severe traumatic brain injury.\n* Patients with an expected mortality in the ICU of more than 80%.\n* Absence of family members for patients admitted to the ICU.",{"count":207,"type":19},122,"The aim of this prospective cohort study was to investigate the effect of the time spent with relatives of patients treated in a tertiary intensive care unit on patient outcomes.\n\nThe main question it aimed to answer was:\n\nDoes spending more time with relatives of patients in intensive care result in lower sedative agent requirements? Does spending more time with relatives of patients in intensive care result in less delirium, fewer ventilator days, and shorter ICU stays?",[210,211,25,212,213],"Intensive Care Patients","Relatives","Sedatives","Family",[215,216,217,212],"Intensive care patients","relatives","Delirium in the intensive care unit","2025-01-15",{"date":220,"type":40},"2025-01-17",{"date":222,"type":40},"2025-01-13",{"date":224,"type":19},"2025-08-15",{"name":226,"class":47},"Istanbul University - Cerrahpasa",{"id":228,"slug":229,"hasResults":11,"nctId":230,"briefTitle":231,"officialTitle":232,"acronym":233,"eligibilityCriteria":234,"healthyVolunteers":15,"sex":16,"minAge":56,"maxAge":4,"enrollmentInfo":235,"targetDuration":4,"studyType":20,"phases":237,"briefSummary":238,"conditions":239,"keywords":241,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":244,"lastUpdatePostDateStruct":245,"startDateStruct":247,"completionDateStruct":249,"leadSponsor":251,"locationsCount":48},"100568470","pilot-feasibility-study-of-a-pragmatic-mixed-methods-randomized-controlled-trial-on-a-follow-up-bundle-of-care-for-icu-survivors-and-caregivers-100568470","NCT06681649","Pilot Feasibility Study of a Pragmatic Mixed-Methods Randomized Controlled Trial on a Follow-Up Bundle of Care for ICU Survivors and Caregivers","Improving Medical and Psychological Outcomes After Discharge - Feasibility Study for a Pragmatic, Mixed-methods, Open-label Randomized Controlled Trial Examining the Effectiveness of a Follow-up Clinic for ICU Survivors and Caregivers","IMPACT-ICU","Inclusion criteria - ICU survivors\n\n1. Adult patients (age greater than or equal to 18 years)\n2. Life expectancy greater than or equal to 6 months as determined by the attending physician\n3. High risk for long-term functional sequelae following ICU discharge, defined as ICU stay greater than or equal to 4 days, or involving at least one of:\n\n   * mechanical ventilation (any, i.e., invasive or non-invasive)\n   * tracheostomy\n   * delirium (defined as Confusion Assessment Method (CAM) positive or documented history of delirium in the patient's medical record by the clinical care team at some point during their ICU admission)\n   * lack of access to a primary care physician for clinical follow-up\n   * access to email or mail to complete follow-up questionnaires\n   * presence of an informal caregiver\n\nInclusion criteria - Caregivers\n\n1. Informal caregiver (e.g., spouse, offspring) for ICU survivor as defined above\n2. Adult (age greater than or equal to 18 years)\n\nExclusion criteria - ICU survivors and caregivers\n\n* Neurological or communication difficulties which would preclude completion of follow-up assessments or participation in focus groups\n* Inability to speak or read English (required for completion of standardized questionnaires, clinical assessments, and for participation in focus groups)\n* Failure to provide consent\u002Ffailure to have consent provided by a substitute decision maker",{"count":236,"type":19},40,[22],"\\~80% of ICU survivors experience profound long-term cognitive, physical, and psychiatric impairments known as post-intensive care syndrome (PICS). Caregivers additionally experience similar detrimental psychosocial effects following discharge. Despite this knowledge, follow-up care is almost non-existent. ICU follow-up clinics may mitigate these long-term impacts, but lack evaluation of their effectiveness. This trial will evaluate the effectiveness of ICU follow-up clinics vs. standard-of-care in improving qualitative\u002Fclinical outcomes of ICU survivors and caregivers, with those receiving follow-up care hypothesized to have improved outcomes.",[240,25],"Critical Illness",[242,64,243],"critical illness","post-intensive care syndrome","2024-11-29",{"date":246,"type":40},"2024-12-04",{"date":248,"type":40},"2024-06-01",{"date":250,"type":19},"2025-06-01",{"name":252,"class":47},"Queen's University"]